Dipeptidyl Peptidase 4 clinical trials
How each study uses Dipeptidyl Peptidase 4 is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Name
- Galvus
- 2
Studies by the year they started
4 studies that test it; most in 2009 (2)
| Year | Studies |
|---|---|
| 2009 | 2 |
| 2017 | 1 |
| 2022 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 0 · Other 4
University Hospital, Gentofte, Copenhagen (2) · Ain Shams University (1) · First Affiliated Hospital Xi'an Jiaotong University (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses Dipeptidyl Peptidase 4 is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 4
- Effect of Dipeptidyl Peptidase- 4 Inhibitors on Non-Alcoholic Steatohepatitis and Type 1 DiabetesCompletedPhase 3Ain Shams UniversityNCT06348706Written as Dipeptidyl peptidase 4 (DPP-4) inhibitorHow we know
- Therapies on Newly Diagnosed Type 2 Diabetes Patients With High Glucose Toxicity Which Protect Islet β CellStatus unknownNot applicableFirst Affiliated Hospital Xi'an Jiaotong UniversityNCT03180281Written as DPP4How we know
- Intact Vagal Innervation for and Glucagon-like Peptide-1 (GLP-1) EffectsStatus unknownNot applicableUniversity Hospital, Gentofte, CopenhagenNCT01176760Written as Dipeptidyl peptidase 4 (DPP 4) inhibitorHow we know
- Intact Liver Innervation and Glucose and Glucagon-like Peptide-1 (GLP-1) Induced Insulin SecretionStatus unknownNot applicableUniversity Hospital, Gentofte, CopenhagenNCT01176708Written as dipeptidyl peptidase 4 (DPP4) inhibitorHow we know
Given beside what is tested · 1 — Dipeptidyl Peptidase 4 is usual care or a partner of the new treatment
- A Study to Evaluate the Effectiveness and Safety Initiation and Titration of Insulin Glargine (U300) in Insulin-naïve Patients With Type 2 Diabetes Mellitus (T2DM) Controlled on Oral Antidiabetic Drug Treatment in TurkeyCompletedPhase 4SanofiNCT02954692Written as Dipeptidyl peptidase-IV (DPP-IV) inhibitorsHow we know